首页 > 最新文献

Birth Defects Research最新文献

英文 中文
Monochorionic triplet pregnancy complicated by conjoined twins and early twin–twin transfusion syndrome 单绒毛膜三胞胎妊娠并发连体双胞胎和早期双胞胎输血综合征。
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-16 DOI: 10.1002/bdr2.2317
Juan Carlos Bustos, Helga Vera, Paz Ahumada, Daniel Martin

Background

The condition of monozygotic, monochorionic triplet fetuses with a pair of conjoined twins is extremely rare (close to one in a million births), presents challenges in its management, and with poor prognosis.

Case report

We report a case of monochorionic diamniotic triplet pregnancy, ultrasound at 14 weeks shows a pair of conjoined thoracopagus fetuses, sharing heart, liver, and umbilical cord, in addition to omphalocele. The third fetus, without malformations, presents signs of early heart failure compatible with twin-to-twin transfusion syndrome. It was decided to carry out expectant management where at 18 weeks, intrauterine death of the three fetuses occurs. An abortion is performed by hysterotomy.

Conclusions

The treatment in these cases is discussed, three management options have been proposed: expectant management, selective reduction of the conjoined fetuses, or termination of the pregnancy. A review of the literature found only 12 cases with this combination of pathologies, in which only 3 normal fetuses (25%) survived and none of the conjoined twins survived. To our knowledge, this case is the first of a monochorionic triplet pregnancy with conjoined fetuses complicated with early twin-to-twin transfusion.

背景:单卵双胎、单绒毛膜三胞胎和一对连体婴儿的情况极为罕见(接近百万分之一),其管理面临挑战,且预后较差:我们报告了一例单绒毛膜双羊膜腔三胎妊娠,14 周时的超声检查显示一对连体胸腔畸形胎儿,共用心脏、肝脏和脐带,此外还有脐膨出。第三个胎儿没有畸形,但出现了早期心衰的迹象,与双胎输血综合征相符。在 18 周时,三个胎儿在宫内死亡。结论:讨论了这些病例的治疗方法:对这些病例的治疗方法进行了讨论,提出了三种处理方案:期待处理、选择性减少连体胎儿或终止妊娠。查阅文献后发现,只有 12 例合并这种病变的病例,其中只有 3 个正常胎儿(25%)存活,连体婴儿无一存活。据我们所知,本病例是首例单绒毛膜三胞胎妊娠合并连体胎儿早期双胎输血的病例。
{"title":"Monochorionic triplet pregnancy complicated by conjoined twins and early twin–twin transfusion syndrome","authors":"Juan Carlos Bustos,&nbsp;Helga Vera,&nbsp;Paz Ahumada,&nbsp;Daniel Martin","doi":"10.1002/bdr2.2317","DOIUrl":"10.1002/bdr2.2317","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The condition of monozygotic, monochorionic triplet fetuses with a pair of conjoined twins is extremely rare (close to one in a million births), presents challenges in its management, and with poor prognosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Case report</h3>\u0000 \u0000 <p>We report a case of monochorionic diamniotic triplet pregnancy, ultrasound at 14 weeks shows a pair of conjoined thoracopagus fetuses, sharing heart, liver, and umbilical cord, in addition to omphalocele. The third fetus, without malformations, presents signs of early heart failure compatible with twin-to-twin transfusion syndrome. It was decided to carry out expectant management where at 18 weeks, intrauterine death of the three fetuses occurs. An abortion is performed by hysterotomy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The treatment in these cases is discussed, three management options have been proposed: expectant management, selective reduction of the conjoined fetuses, or termination of the pregnancy. A review of the literature found only 12 cases with this combination of pathologies, in which only 3 normal fetuses (25%) survived and none of the conjoined twins survived. To our knowledge, this case is the first of a monochorionic triplet pregnancy with conjoined fetuses complicated with early twin-to-twin transfusion.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139740399","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selenium mitigates methotrexate-induced testicular injury: Insights from male NMRI mice model 硒可减轻甲氨蝶呤引起的睾丸损伤:雄性 NMRI 小鼠模型的启示。
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-13 DOI: 10.1002/bdr2.2315
Mohammadreza Gholami, Afsaneh Nemati, Azita Alasvand Zarasvand, Abolfazl Zendehdel, Cyrus Jalili, Iraj Rashidi, Kamran Mansouri, Forough Taheri, Vahideh Assadollahi, Elham Gholami

Background and Aim

Chemotherapy, particularly with methotrexate (MTX), often elicits testicular toxicity, leading to impaired spermatogenesis and hormone imbalances. This study aimed to investigate the potential protective effects of selenium (Se) against MTX-induced testicular injury.

Materials and Methods

Male mice were divided into control, MTX, Se, and MTX + Se groups. Histopathological examination involved the preparation of testicular tissue sections using the Johnsen's tubular biopsy score (JTBS) for spermatogenesis evaluation. Biochemical tests included the assessment of testosterone, malondialdehyde (MDA), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels. Real-time quantitative polymerase chain reaction (RT-qPCR) was employed to analyze the expression of caspase 3 (casp3), tumor protein 53 (p53), B-cell lymphoma 2 (Bcl2), and Bcl2-associated X protein (Bax) genes. Statistical analysis was performed using ANOVA and Tukey's tests (p < .05).

Results

Histopathological analysis revealed significant testicular damage in the MTX group, with decreased spermatogenesis and Leydig cell count, while Se administration mitigated these effects, preserving the structural integrity of the reproductive epithelium. Biochemical analysis demonstrated that MTX led to elevated malondialdehyde (MDA) levels and reduced testosterone, LH, and FSH levels, suggesting oxidative stress and Leydig cell dysfunction. Gene expression analysis indicated that MTX upregulated proapoptotic genes (casp3, p53, and bax) while downregulating the antiapoptotic Bcl2 gene. In contrast, Se treatment reversed these trends, highlighting its potential antiapoptotic properties.

Conclusion

Our findings underscore the potential of Se as a therapeutic agent to mitigate the reproductive toxicity associated with MTX-induced testicular injury. Se exerts protective effects by regulating oxidative stress, preserving hormone balance, and modulating apoptotic pathways. These results suggest that Se supplementation could be a promising strategy to alleviate chemotherapy-induced testicular damage and preserve male fertility.

背景和目的:化疗,尤其是甲氨蝶呤(MTX),经常引起睾丸毒性,导致精子发生障碍和激素失衡。本研究旨在探讨硒(Se)对 MTX 引起的睾丸损伤的潜在保护作用:雄性小鼠分为对照组、MTX 组、Se 组和 MTX + Se 组。组织病理学检查包括使用约翰森小管活检评分法(JTBS)制备睾丸组织切片,以评估精子发生情况。生化检验包括评估睾酮、丙二醛(MDA)、黄体生成素(LH)和促卵泡激素(FSH)水平。采用实时定量聚合酶链反应(RT-qPCR)分析了caspase 3(casp3)、肿瘤蛋白53(p53)、B细胞淋巴瘤2(Bcl2)和Bcl2相关X蛋白(Bax)基因的表达。统计分析采用方差分析和 Tukey 检验(P 结果):组织病理学分析表明,MTX 组睾丸明显受损,精子发生和雷迪格细胞数量减少,而 Se 组则减轻了这些影响,保持了生殖上皮细胞结构的完整性。生化分析表明,MTX导致丙二醛(MDA)水平升高,睾酮、LH和FSH水平降低,表明存在氧化应激和Leydig细胞功能障碍。基因表达分析表明,MTX 上调了促凋亡基因(casp3、p53 和 bax),同时下调了抗凋亡基因 Bcl2。与此相反,Se 治疗逆转了这些趋势,凸显了其潜在的抗凋亡特性:我们的研究结果强调了Se作为一种治疗剂,减轻MTX诱导的睾丸损伤相关生殖毒性的潜力。Se 可通过调节氧化应激、保持激素平衡和调节细胞凋亡途径发挥保护作用。这些结果表明,补充Se可能是减轻化疗引起的睾丸损伤和保护男性生育能力的一种有前途的策略。
{"title":"Selenium mitigates methotrexate-induced testicular injury: Insights from male NMRI mice model","authors":"Mohammadreza Gholami,&nbsp;Afsaneh Nemati,&nbsp;Azita Alasvand Zarasvand,&nbsp;Abolfazl Zendehdel,&nbsp;Cyrus Jalili,&nbsp;Iraj Rashidi,&nbsp;Kamran Mansouri,&nbsp;Forough Taheri,&nbsp;Vahideh Assadollahi,&nbsp;Elham Gholami","doi":"10.1002/bdr2.2315","DOIUrl":"10.1002/bdr2.2315","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background and Aim</h3>\u0000 \u0000 <p>Chemotherapy, particularly with methotrexate (MTX), often elicits testicular toxicity, leading to impaired spermatogenesis and hormone imbalances. This study aimed to investigate the potential protective effects of selenium (Se) against MTX-induced testicular injury.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>Male mice were divided into control, MTX, Se, and MTX + Se groups. Histopathological examination involved the preparation of testicular tissue sections using the Johnsen's tubular biopsy score (JTBS) for spermatogenesis evaluation. Biochemical tests included the assessment of testosterone, malondialdehyde (MDA), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) levels. Real-time quantitative polymerase chain reaction (RT-qPCR) was employed to analyze the expression of caspase 3 (casp3), tumor protein 53 (p53), B-cell lymphoma 2 (Bcl2), and Bcl2-associated X protein (Bax) genes. Statistical analysis was performed using ANOVA and Tukey's tests (<i>p</i> &lt; .05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Histopathological analysis revealed significant testicular damage in the MTX group, with decreased spermatogenesis and Leydig cell count, while Se administration mitigated these effects, preserving the structural integrity of the reproductive epithelium. Biochemical analysis demonstrated that MTX led to elevated malondialdehyde (MDA) levels and reduced testosterone, LH, and FSH levels, suggesting oxidative stress and Leydig cell dysfunction. Gene expression analysis indicated that MTX upregulated proapoptotic genes (casp3, p53, and bax) while downregulating the antiapoptotic Bcl2 gene. In contrast, Se treatment reversed these trends, highlighting its potential antiapoptotic properties.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Our findings underscore the potential of Se as a therapeutic agent to mitigate the reproductive toxicity associated with MTX-induced testicular injury. Se exerts protective effects by regulating oxidative stress, preserving hormone balance, and modulating apoptotic pathways. These results suggest that Se supplementation could be a promising strategy to alleviate chemotherapy-induced testicular damage and preserve male fertility.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of craniosynostosis in Finland, 1987–2010: A population-based study 1987-2010年芬兰颅畸形发病率:一项基于人口的研究。
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-13 DOI: 10.1002/bdr2.2319
Pia Vuola, Niklas Pakkasjärvi, Annukka Ritvanen, Arja Heliövaara, Erkki Tukiainen, Mika Gissler

Background

Craniosynostosis is a prevalent craniofacial malformation in Finland; however, comprehensive population-based epidemiological data are limited. This study aimed to estimate the total and birth prevalence of craniosynostosis in Finland from 1987 to 2010 and examine temporal trends.

Methods

We collected the data from nationwide registers maintained by the Finnish Institute for Health and Welfare and Statistics Finland, as well as treating hospitals, encompassing live births, stillbirths, terminations for fetal anomalies, and infant deaths with suspected or diagnosed craniosynostosis or skull deformation. A craniofacial surgeon and a clinical geneticist reviewed 1878 medical records for diagnostic confirmation.

Results

Out of 877 craniosynostosis cases, 83% were single-suture synostoses (all live births), 10% craniosynostosis syndromes, and 7% multisutural non-syndromic synostoses. Live birth prevalence from 1987 to 2010 was 6.0/10,000 live births, ranging from 5.0/10,000 in 1987 to 7.5/10,000 in 2010. Total prevalence, including live births, stillbirths, and terminations, varied from 5.0/10,000 in 1987 to 8.0/10,000 in 2010. Sagittal synostosis was the most common synostosis, with a prevalence of 3.9/10,000 live births, followed by metopic (0.6/10,000), unicoronal (0.4/10,000), and unilambdoid (0.1/10,000) synostoses.

Conclusions

The total combined prevalence of all craniosynostosis types significantly increased driven by a nonsignificant rise across all subgroups and a significant increase in the syndrome group. In live births increase was significant only within the syndrome subgroup, primarily due to an increase in Muenke syndrome patients. The rising prevalence of syndromes necessitates further investigation. Contrasting with trends in Europe, Australia, and the USA, Finland showed no significant increase in metopic craniosynostosis.

背景:在芬兰,颅畸形是一种常见的颅面畸形;然而,基于人口的综合流行病学数据却很有限。本研究旨在估算1987年至2010年芬兰颅畸形的总患病率和出生患病率,并研究其时间趋势:我们从芬兰卫生与福利研究所(Finnish Institute for Health and Welfare)和芬兰统计局(Statistics Finland)保存的全国登记册以及治疗医院收集数据,包括活产、死产、胎儿畸形终止妊娠以及疑似或诊断为颅骨发育不良或颅骨畸形的婴儿死亡。一名颅面外科医生和一名临床遗传学家审查了 1878 份病历,以进行诊断确认:结果:在 877 例颅突症病例中,83% 为单缝合颅突症(均为活产),10% 为颅突症综合征,7% 为多缝合颅突症(非综合征)。1987年至2010年的活产患病率为6.0/10,000,1987年为5.0/10,000,2010年为7.5/10,000。包括活产、死产和终止妊娠在内的总患病率从1987年的5.0/10,000到2010年的8.0/10,000不等。矢状突胸是最常见的突胸,发病率为 3.9/10,000,其次是偏侧突胸(0.6/10,000)、单冠突胸(0.4/10,000)和单斜突胸(0.1/10,000):结论:所有颅突症类型的总合患病率显著增加,所有亚组的患病率均无显著增加,而综合征组的患病率显著增加。只有在综合征亚组中,活产婴儿的发病率才有显著增长,这主要是由于穆恩科综合征患者的增加。综合症发病率的上升需要进一步调查。与欧洲、澳大利亚和美国的趋势不同,芬兰的偏头颅畸形没有明显增加。
{"title":"Prevalence of craniosynostosis in Finland, 1987–2010: A population-based study","authors":"Pia Vuola,&nbsp;Niklas Pakkasjärvi,&nbsp;Annukka Ritvanen,&nbsp;Arja Heliövaara,&nbsp;Erkki Tukiainen,&nbsp;Mika Gissler","doi":"10.1002/bdr2.2319","DOIUrl":"10.1002/bdr2.2319","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Craniosynostosis is a prevalent craniofacial malformation in Finland; however, comprehensive population-based epidemiological data are limited. This study aimed to estimate the total and birth prevalence of craniosynostosis in Finland from 1987 to 2010 and examine temporal trends.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We collected the data from nationwide registers maintained by the Finnish Institute for Health and Welfare and Statistics Finland, as well as treating hospitals, encompassing live births, stillbirths, terminations for fetal anomalies, and infant deaths with suspected or diagnosed craniosynostosis or skull deformation. A craniofacial surgeon and a clinical geneticist reviewed 1878 medical records for diagnostic confirmation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Out of 877 craniosynostosis cases, 83% were single-suture synostoses (all live births), 10% craniosynostosis syndromes, and 7% multisutural non-syndromic synostoses. Live birth prevalence from 1987 to 2010 was 6.0/10,000 live births, ranging from 5.0/10,000 in 1987 to 7.5/10,000 in 2010. Total prevalence, including live births, stillbirths, and terminations, varied from 5.0/10,000 in 1987 to 8.0/10,000 in 2010. Sagittal synostosis was the most common synostosis, with a prevalence of 3.9/10,000 live births, followed by metopic (0.6/10,000), unicoronal (0.4/10,000), and unilambdoid (0.1/10,000) synostoses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>The total combined prevalence of all craniosynostosis types significantly increased driven by a nonsignificant rise across all subgroups and a significant increase in the syndrome group. In live births increase was significant only within the syndrome subgroup, primarily due to an increase in Muenke syndrome patients. The rising prevalence of syndromes necessitates further investigation. Contrasting with trends in Europe, Australia, and the USA, Finland showed no significant increase in metopic craniosynostosis.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdr2.2319","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Climate and environmental changes exacerbate health disparities in pregnant people and their offspring. How can we protect women and their babies? 气候和环境变化加剧了孕妇及其后代的健康差异。我们该如何保护妇女及其婴儿?
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-13 DOI: 10.1002/bdr2.2313
Guillermina Girardi, Andrew A. Bremer

Background

The effects of climate and environmental changes (CEC) are being felt globally and will worsen over the next decade unless significant changes are made on a global level. Climate change is having serious consequences for health, particularly for vulnerable women and their offspring and less resilient individuals in communities with socioeconomic inequalities. To protect human health from CEC effects, efforts need to be directed toward building resilience strategies. Building political and economic power, as well as directly addressing CEC-related challenges, are critical components of climate resilience. Effective communication and tailored methods to engage women in preventive strategies are also necessary to ameliorate the deleterious effects of CEC on women's health. Furthermore, women from marginalized communities face more CEC-associated challenges.

Conclusions

Therefore, effective policies and programs targeting these at-risk populations—are crucial to improve the overall state of global health. In closing, it is time to increase awareness of the effects of CECs on women's health and their transgenerational effects in order to ensure that all people, regardless of race, ethnicity, education and income are protected from the detrimental effects of CECs.

背景:全球都能感受到气候和环境变化(CEC)的影响,除非在全球范围内做出重大改变,否则这种影响将在未来十年内加剧。气候变化正在对健康造成严重后果,尤其是对弱势妇女及其后代,以及社会经济不平等社区中抗灾能力较弱的个人。为了保护人类健康免受气候变化的影响,需要努力制定抗灾战略。建立政治和经济力量以及直接应对与《气候公约》相关的挑战,是气候复原力的关键组成部分。有效的沟通和量身定制的方法让妇女参与预防性战略也是改善《气候公约》对妇女健康的有害影响所必需的。此外,来自边缘化社区的妇女面临着更多与气候变化相关的挑战:因此,针对这些高危人群的有效政策和计划对于改善全球整体健康状况至关重要。最后,现在是时候提高人们对 CEC 对妇女健康的影响及其跨代影响的认识了,以确保所有人,无论种族、民族、教育程度和收入如何,都能免受 CEC 的有害影响。
{"title":"Climate and environmental changes exacerbate health disparities in pregnant people and their offspring. How can we protect women and their babies?","authors":"Guillermina Girardi,&nbsp;Andrew A. Bremer","doi":"10.1002/bdr2.2313","DOIUrl":"10.1002/bdr2.2313","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The effects of climate and environmental changes (CEC) are being felt globally and will worsen over the next decade unless significant changes are made on a global level. Climate change is having serious consequences for health, particularly for vulnerable women and their offspring and less resilient individuals in communities with socioeconomic inequalities. To protect human health from CEC effects, efforts need to be directed toward building resilience strategies. Building political and economic power, as well as directly addressing CEC-related challenges, are critical components of climate resilience. Effective communication and tailored methods to engage women in preventive strategies are also necessary to ameliorate the deleterious effects of CEC on women's health. Furthermore, women from marginalized communities face more CEC-associated challenges.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Therefore, effective policies and programs targeting these at-risk populations—are crucial to improve the overall state of global health. In closing, it is time to increase awareness of the effects of CECs on women's health and their transgenerational effects in order to ensure that all people, regardless of race, ethnicity, education and income are protected from the detrimental effects of CECs.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139721602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case-control study characterizing polydactyly risk factors in Bogotá and Cali, Colombia between 2002 and 2020 2002 至 2020 年哥伦比亚波哥大和卡利多指畸形风险因素的病例对照研究
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-11 DOI: 10.1002/bdr2.2312
Esteban Portilla-Rojas, Lina Ramírez, Camilo Moreno, Juliana Lores, Karen Sarmiento, Ignacio Zarante

Background

Polydactyly is a congenital abnormality characterized by the presence of additional fingers on one or more extremities. In Colombia, polydactyly accounted for 17% of musculoskeletal congenital abnormalities in 2021, with a prevalence of 6.03 per 10,000 live births. The purpose of this study was to determine the prevalence of polydactyly and identify associated risk factors in Bogotá and Cali, Colombia, from 2002 to 2020.

Methods

A retrospective case-control study design was employed, analyzing data from birth defect reports provided by the Program for the Prevention and Follow-up of Congenital Defects and Orphan Diseases surveillance system. Cases included live births or stillbirths with polydactyly, while controls consisted of infants without congenital abnormality, matched in terms of birth date and hospital. Prevalence of polydactyly was calculated and risk factors were assessed through odds ratios obtained by logistic regression models, considering a 95% confidence interval.

Results

Among the 558,255 births included in the study, 848 cases of polydactyly were identified, resulting in a prevalence rate of 15.19 per 10,000 live births. Risk factors associated with polydactyly included male newborn sex, pregestational diabetes, and a family history of malformation among first-degree relatives.

Conclusion

These findings highlight the importance a surveillance system aimed to characterize populations with congenital abnormalities, providing a better option for analyzing risk factors, help improving prevention, diagnosis, notification, and optimal treatment in patients.

背景多指畸形是一种先天性畸形,其特征是一个或多个肢体上有额外的手指。在哥伦比亚,多指畸形占 2021 年肌肉骨骼先天畸形的 17%,发病率为每 10,000 名活产婴儿中有 6.03 例。本研究旨在确定 2002 年至 2020 年哥伦比亚波哥大和卡利地区多指畸形的发病率,并识别相关风险因素。 方法 采用回顾性病例对照研究设计,分析先天性缺陷和孤儿疾病预防和跟踪计划监控系统提供的出生缺陷报告数据。病例包括患有多指畸形的活产或死产婴儿,而对照组则包括无先天性异常的婴儿,出生日期和医院均匹配。计算多指畸形的患病率,并通过逻辑回归模型得出的几率比(考虑 95% 的置信区间)评估风险因素。 结果 在纳入研究的 558 255 名新生儿中,发现了 848 例多指畸形,患病率为每万名活产婴儿 15.19 例。多指畸形的相关风险因素包括新生儿性别为男性、孕前糖尿病以及一级亲属中有畸形家族史。 结论 这些发现凸显了监测系统的重要性,该系统旨在描述先天性畸形人群的特征,为分析风险因素提供更好的选择,有助于改善预防、诊断、通知和对患者的最佳治疗。
{"title":"A case-control study characterizing polydactyly risk factors in Bogotá and Cali, Colombia between 2002 and 2020","authors":"Esteban Portilla-Rojas,&nbsp;Lina Ramírez,&nbsp;Camilo Moreno,&nbsp;Juliana Lores,&nbsp;Karen Sarmiento,&nbsp;Ignacio Zarante","doi":"10.1002/bdr2.2312","DOIUrl":"https://doi.org/10.1002/bdr2.2312","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Polydactyly is a congenital abnormality characterized by the presence of additional fingers on one or more extremities. In Colombia, polydactyly accounted for 17% of musculoskeletal congenital abnormalities in 2021, with a prevalence of 6.03 per 10,000 live births. The purpose of this study was to determine the prevalence of polydactyly and identify associated risk factors in Bogotá and Cali, Colombia, from 2002 to 2020.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>A retrospective case-control study design was employed, analyzing data from birth defect reports provided by the Program for the Prevention and Follow-up of Congenital Defects and Orphan Diseases surveillance system. Cases included live births or stillbirths with polydactyly, while controls consisted of infants without congenital abnormality, matched in terms of birth date and hospital. Prevalence of polydactyly was calculated and risk factors were assessed through odds ratios obtained by logistic regression models, considering a 95% confidence interval.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among the 558,255 births included in the study, 848 cases of polydactyly were identified, resulting in a prevalence rate of 15.19 per 10,000 live births. Risk factors associated with polydactyly included male newborn sex, pregestational diabetes, and a family history of malformation among first-degree relatives.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>These findings highlight the importance a surveillance system aimed to characterize populations with congenital abnormalities, providing a better option for analyzing risk factors, help improving prevention, diagnosis, notification, and optimal treatment in patients.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139719864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
HESI workshop summary: Interpretation of developmental and reproductive toxicity endpoints and the impact on data interpretation of adverse events HESI 研讨会摘要:发育和生殖毒性终点的解释及对不良事件数据解释的影响
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-11 DOI: 10.1002/bdr2.2311
M. L. Green, A. Kluever, Connie Chen, S. Dobreniecki, Wendy Halpern, Bethany Hannas, Alan Hoberman, M. E. McNerney, S. Mitchell-Ryan, T. J. Shafer, Steven Van Cruchten, Tacey White

The Health and Environmental Sciences Institute Developmental and Reproductive Toxicology (HESI-DART) group held a hybrid in-person and virtual workshop in Washington, DC, in 2022. The workshop was entitled, “Interpretation of DART in Regulatory Contexts and Frameworks.” There were 154 participants (37 in person and 117 virtual) across 9 countries. The purpose of the workshop was to capture key consensus approaches used to assess DART risks associated with chemical product exposure when a nonclinical finding is identified. The decision-making process for determining whether a DART endpoint is considered adverse is critical because the outcome may have downstream implications (e.g., increased animal usage, modifications to reproductive classification and pregnancy labeling, impact on enrollment in clinical trials and value chains). The workshop included a series of webinar modules to train and engage in discussions with federal and international regulators, clinicians, academic investigators, nongovernmental organizations, contract research organization scientists, and private sector scientists on the best practices and principles of interpreting DART and new approach methodologies in the context of regulatory requirements and processes. Despite the differences in regulatory frameworks between the chemical and pharmaceutical sectors, the same foundational principles for data interpretation should be applied. The discussions led to the categorization of principles, which offer guidance for the systematic interpretation of data. Step 1 entails identifying any hazard by closely analyzing the data at the study endpoint level, while Step 2 involves assessing risk using weight of evidence. These guiding principles were derived from the collective outcomes of the workshop deliberations.

2022 年,健康与环境科学研究所发育与生殖毒理学(HESI-DART)小组在华盛顿特区举办了一次现场与虚拟混合研讨会。研讨会的主题是 "监管背景和框架下的 DART 解释"。来自 9 个国家的 154 名与会者(37 名亲临现场,117 名虚拟与会者)参加了此次研讨会。研讨会的目的是收集关键的共识方法,用于在发现非临床发现时评估与化学产品暴露相关的 DART 风险。确定 DART 终点是否被视为不利因素的决策过程至关重要,因为其结果可能会产生下游影响(例如,增加动物用量、修改生殖分类和妊娠标签、影响临床试验和价值链的注册)。研讨会包括一系列网络研讨会模块,对联邦和国际监管机构、临床医生、学术研究人员、非政府组织、合同研究组织科学家和私营部门科学家进行培训,并与他们讨论在监管要求和流程背景下解释 DART 和新方法学的最佳实践和原则。尽管化学和制药部门的监管框架不同,但数据解读的基本原则应该相同。通过讨论,对原则进行了分类,为系统解释数据提供了指导。第 1 步需要通过仔细分析研究终点层面的数据来确定任何危害,而第 2 步则涉及使用证据权重来评估风险。这些指导原则源自研讨会的集体讨论结果。
{"title":"HESI workshop summary: Interpretation of developmental and reproductive toxicity endpoints and the impact on data interpretation of adverse events","authors":"M. L. Green,&nbsp;A. Kluever,&nbsp;Connie Chen,&nbsp;S. Dobreniecki,&nbsp;Wendy Halpern,&nbsp;Bethany Hannas,&nbsp;Alan Hoberman,&nbsp;M. E. McNerney,&nbsp;S. Mitchell-Ryan,&nbsp;T. J. Shafer,&nbsp;Steven Van Cruchten,&nbsp;Tacey White","doi":"10.1002/bdr2.2311","DOIUrl":"https://doi.org/10.1002/bdr2.2311","url":null,"abstract":"<p>The Health and Environmental Sciences Institute Developmental and Reproductive Toxicology (HESI-DART) group held a hybrid in-person and virtual workshop in Washington, DC, in 2022. The workshop was entitled, “Interpretation of DART in Regulatory Contexts and Frameworks.” There were 154 participants (37 in person and 117 virtual) across 9 countries. The purpose of the workshop was to capture key consensus approaches used to assess DART risks associated with chemical product exposure when a nonclinical finding is identified. The decision-making process for determining whether a DART endpoint is considered adverse is critical because the outcome may have downstream implications (e.g., increased animal usage, modifications to reproductive classification and pregnancy labeling, impact on enrollment in clinical trials and value chains). The workshop included a series of webinar modules to train and engage in discussions with federal and international regulators, clinicians, academic investigators, nongovernmental organizations, contract research organization scientists, and private sector scientists on the best practices and principles of interpreting DART and new approach methodologies in the context of regulatory requirements and processes. Despite the differences in regulatory frameworks between the chemical and pharmaceutical sectors, the same foundational principles for data interpretation should be applied. The discussions led to the categorization of principles, which offer guidance for the systematic interpretation of data. Step 1 entails identifying any hazard by closely analyzing the data at the study endpoint level, while Step 2 involves assessing risk using weight of evidence. These guiding principles were derived from the collective outcomes of the workshop deliberations.</p>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/bdr2.2311","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139719885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transmission of behavioral and cognitive impairments across generations in rats subjected to prenatal valproic acid exposure 产前接触丙戊酸的大鼠行为和认知障碍的跨代传递
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-11 DOI: 10.1002/bdr2.2309
Farahnaz Taheri, Sara Joushi, Khadijeh Esmaeilpour, Mohammad Navid Ebrahimi, Zahra Taherizadeh, Parichehr Taheri, Vahid Sheibani

Background

Autism spectrum disorder (ASD) represents an inheritable neurodevelopmental condition characterized by social communication deficits and repetitive behaviors. Numerous studies have underscored the significant roles played by genetic and environmental factors in the etiology of ASD, and these factors are known to perpetuate behavioral impairments across generations.

Objectives

The primary objective of this study was to assess the behavioral and cognitive attributes in the second filial (F2) generation of male and female rats, with a particular focus on those whose parents had been exposed to valproic acid (VPA) during embryonic development.

Methods

In this study, a cohort of 32 male and 32 female rats from the second filial (F2) generation, referred to as Mother.ASD, Father.ASD, or Both.ASD, was examined. These designations indicate whether the mother, father, or both parents had experienced embryonic exposure to valproic acid (600 mg/kg, i.p.). During adolescence, the F2 pups underwent behavioral and cognitive assessments, including open field testing, marble burying, social interaction evaluations, and Morris water maze tasks.

Results

Our data revealed that while both the Mother.ASD and Father.ASD groups, regardless of sex, exhibited elevated anxiety-like behavior in the open field test. Only the Mother.ASD group displayed repetitive behaviors and deficits in social memory. Additionally, spatial memory impairments were observed in both sexes. These findings highlight the transmission of autistic-like behaviors in the offspring of Mother.ASD rats from both sexes. Nevertheless, future research endeavors should be more targeted in identifying the specific genes responsible for this transmission.

Conclusion

In summary, our findings underscore the transmission of autistic-like behaviors, including anxiety-like behavior, repetitive actions, impairments in social interactions, and deficits in memory, to the offspring of the Mother.ASD group, irrespective of their sex.

背景 自闭症谱系障碍(ASD)是一种可遗传的神经发育疾病,其特点是社交沟通障碍和重复行为。大量研究强调了遗传和环境因素在自闭症谱系障碍病因中的重要作用,而且众所周知,这些因素会使行为障碍代代相传。 目的 本研究的主要目的是评估雌雄大鼠第二代孝子(F2)的行为和认知属性,尤其关注那些父母在胚胎发育期间接触过丙戊酸(VPA)的大鼠。 方法 在这项研究中,我们对第二代孝子(F2)中的 32 只雄性大鼠和 32 只雌性大鼠进行了研究,这些大鼠被称为母亲 ASD、父亲 ASD 或双亲 ASD。这些名称表示母亲、父亲或父母双方在胚胎期是否接触过丙戊酸(600 毫克/千克,静脉注射)。在青春期,F2 幼崽接受了行为和认知评估,包括开阔地测试、埋弹珠、社会互动评估和莫里斯水迷宫任务。 结果 我们的数据显示,母亲ASD组和父亲ASD组,无论性别如何,都在野外测试中表现出焦虑行为。只有母亲ASD组表现出重复行为和社会记忆缺陷。此外,男女儿童都出现了空间记忆障碍。这些发现突显了母亲型自闭症大鼠的后代中自闭症样行为的传播。然而,未来的研究工作应更有针对性地确定造成这种遗传的特定基因。 结论 总之,我们的研究结果表明,自闭症样行为,包括焦虑样行为、重复性动作、社会交往障碍和记忆缺陷,会遗传给 Mother.ASD 组的后代,不论其性别如何。
{"title":"Transmission of behavioral and cognitive impairments across generations in rats subjected to prenatal valproic acid exposure","authors":"Farahnaz Taheri,&nbsp;Sara Joushi,&nbsp;Khadijeh Esmaeilpour,&nbsp;Mohammad Navid Ebrahimi,&nbsp;Zahra Taherizadeh,&nbsp;Parichehr Taheri,&nbsp;Vahid Sheibani","doi":"10.1002/bdr2.2309","DOIUrl":"https://doi.org/10.1002/bdr2.2309","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Autism spectrum disorder (ASD) represents an inheritable neurodevelopmental condition characterized by social communication deficits and repetitive behaviors. Numerous studies have underscored the significant roles played by genetic and environmental factors in the etiology of ASD, and these factors are known to perpetuate behavioral impairments across generations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objectives</h3>\u0000 \u0000 <p>The primary objective of this study was to assess the behavioral and cognitive attributes in the second filial (F2) generation of male and female rats, with a particular focus on those whose parents had been exposed to valproic acid (VPA) during embryonic development.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this study, a cohort of 32 male and 32 female rats from the second filial (F2) generation, referred to as Mother.ASD, Father.ASD, or Both.ASD, was examined. These designations indicate whether the mother, father, or both parents had experienced embryonic exposure to valproic acid (600 mg/kg, i.p.). During adolescence, the F2 pups underwent behavioral and cognitive assessments, including open field testing, marble burying, social interaction evaluations, and Morris water maze tasks.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Our data revealed that while both the Mother.ASD and Father.ASD groups, regardless of sex, exhibited elevated anxiety-like behavior in the open field test. Only the Mother.ASD group displayed repetitive behaviors and deficits in social memory. Additionally, spatial memory impairments were observed in both sexes. These findings highlight the transmission of autistic-like behaviors in the offspring of Mother.ASD rats from both sexes. Nevertheless, future research endeavors should be more targeted in identifying the specific genes responsible for this transmission.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In summary, our findings underscore the transmission of autistic-like behaviors, including anxiety-like behavior, repetitive actions, impairments in social interactions, and deficits in memory, to the offspring of the Mother.ASD group, irrespective of their sex.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139719863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997–2011 1997-2011年全国出生缺陷预防研究中孕早期抗真菌药物的使用与先天性心脏缺陷的风险
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-11 DOI: 10.1002/bdr2.2308
Eleni A. Papadopoulos, Meredith M. Howley, Sarah C. Fisher, Alissa R. Van Zutphen, Martha M. Werler, Paul A. Romitti, Marilyn L. Browne, for the National Birth Defects Prevention Study

Background

Fungal infections are common among pregnant people. Recent studies suggest positive associations between oral antifungals used to treat fungal infections and congenital heart defects (CHDs).

Methods

We estimated associations between first trimester antifungal use and 20 major, specific CHDs using data from the National Birth Defects Prevention Study (NBDPS), a multi-site, case–control study that included pregnancies with estimated delivery dates from October 1997 through December 2011. Infants with CHDs (“cases”) were ascertained from 10 birth defect surveillance programs. Live born infants without major birth defects (“controls”) were randomly selected from birth records or hospital discharge lists. First trimester antifungal use was self-reported via maternal interview. We estimated adjusted odds ratios (AORs) and 95% confidence intervals (CIs) using logistic regression with Firth's penalized likelihood.

Results

First trimester antifungal use was reported by 148/11,653 (1.3%) case and 123/11,427 (1.1%) control participants. We estimated AORs for 12 CHDs; six had AORs >1.5 (tetralogy of Fallot, double outlet right ventricle with transposition of the great arteries [DORV-TGA], atrioventricular septal defect, hypoplastic left heart syndrome, pulmonary atresia, muscular ventricular septal defect), and one (pulmonary valve stenosis) had an AOR <0.7. All CIs included the null, except for DORV-TGA.

Conclusions

First trimester antifungal use was rare. We observed some positive associations for several specific CHDs in our analysis, although the CIs largely included the null. Results do not support a large increase in risk, but smaller increases in risk for certain CHD cannot be ruled out.

背景 真菌感染在孕妇中很常见。最近的研究表明,用于治疗真菌感染的口服抗真菌药与先天性心脏缺陷(CHD)之间存在正相关。 方法 我们利用全国出生缺陷预防研究(NBDPS)的数据估算了怀孕头三个月使用抗真菌药物与 20 种主要的特定先天性心脏病之间的关系,NBDPS 是一项多地点病例对照研究,研究对象包括估计分娩日期为 1997 年 10 月至 2011 年 12 月的孕妇。患有先天性心脏病的婴儿("病例")来自 10 个出生缺陷监测项目。无重大出生缺陷的活产婴儿("对照组")从出生记录或出院名单中随机抽取。孕期前三个月使用抗真菌药物的情况是通过产妇访谈自我报告的。我们使用逻辑回归和 Firth 惩罚似然法估算了调整后的几率比(AOR)和 95% 的置信区间(CI)。 结果 148/11,653 例病例(1.3%)和 123/11,427 例对照组病例(1.1%)报告了孕期前三个月使用抗真菌药物的情况。我们估计了 12 种先天性心脏病的 AOR,其中 6 种的 AOR 为 1.5(法洛氏四联症、双出口右心室伴大动脉转位 [DORV-TGA]、房室间隔缺损、左心发育不全综合征、肺动脉闭锁、肌性室间隔缺损),1 种(肺动脉瓣狭窄)的 AOR 为 0.7。除 DORV-TGA 外,所有 CI 均包括 null。 结论 怀孕头三个月使用抗真菌药物的情况很少见。在我们的分析中,我们观察到与几种特定的先天性心脏病存在一些正相关关系,尽管 CIs 大多包含空值。结果不支持风险的大幅增加,但不能排除某些先心病风险的小幅增加。
{"title":"Antifungal medication use during early pregnancy and the risk of congenital heart defects in the National Birth Defects Prevention Study, 1997–2011","authors":"Eleni A. Papadopoulos,&nbsp;Meredith M. Howley,&nbsp;Sarah C. Fisher,&nbsp;Alissa R. Van Zutphen,&nbsp;Martha M. Werler,&nbsp;Paul A. Romitti,&nbsp;Marilyn L. Browne,&nbsp;for the National Birth Defects Prevention Study","doi":"10.1002/bdr2.2308","DOIUrl":"https://doi.org/10.1002/bdr2.2308","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Fungal infections are common among pregnant people. Recent studies suggest positive associations between oral antifungals used to treat fungal infections and congenital heart defects (CHDs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We estimated associations between first trimester antifungal use and 20 major, specific CHDs using data from the National Birth Defects Prevention Study (NBDPS), a multi-site, case–control study that included pregnancies with estimated delivery dates from October 1997 through December 2011. Infants with CHDs (“cases”) were ascertained from 10 birth defect surveillance programs. Live born infants without major birth defects (“controls”) were randomly selected from birth records or hospital discharge lists. First trimester antifungal use was self-reported via maternal interview. We estimated adjusted odds ratios (AORs) and 95% confidence intervals (CIs) using logistic regression with Firth's penalized likelihood.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>First trimester antifungal use was reported by 148/11,653 (1.3%) case and 123/11,427 (1.1%) control participants. We estimated AORs for 12 CHDs; six had AORs &gt;1.5 (tetralogy of Fallot, double outlet right ventricle with transposition of the great arteries [DORV-TGA], atrioventricular septal defect, hypoplastic left heart syndrome, pulmonary atresia, muscular ventricular septal defect), and one (pulmonary valve stenosis) had an AOR &lt;0.7. All CIs included the null, except for DORV-TGA.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>First trimester antifungal use was rare. We observed some positive associations for several specific CHDs in our analysis, although the CIs largely included the null. Results do not support a large increase in risk, but smaller increases in risk for certain CHD cannot be ruled out.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139719862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prenatal exposure to pesticide mixture in Argentina: A pilot study in puerperal women from Santa Fe province 阿根廷产前接触农药混合物的情况:对圣菲省产褥期妇女的试点研究
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-02-06 DOI: 10.1002/bdr2.2307
Carlina Leila Colussi, Guillaume Martinez, Jean-Philippe Bellenger, Gisela Laura Poletta, María Fernanda Simoniello

Introduction

The epidemiological investigation of congenital anomalies (CA) represents a challenge due to the multiplicity of associated risk factors, notably environmental ones. The monitoring of genotoxic effects in different populations is a useful tool in human biomonitoring and has great biological importance in estimating the exposure risks to complex mixtures of chemical substances.

Objective

This study aimed to determine the presence of environmental xenobiotics and evaluate their genotoxic effect, in mothers of newborns with and without CA, and the possible association/correlation between those biomarkers and CA.

Materials and methods

A descriptive case and control cross-sectional study was developed on 290 postpartum women from Santa Fe, Argentina.

Results

Significant differences were observed between both groups, for places of residence and gynecological variables. Metabolites of organochlorine (OC), organophosphate (OP), and pyrethroid (PYR) pesticides were detected. The most frequently detected compounds were atrazine (ATZ) (57.14%), carbendazim (CBZ) (46.42%), and methylparaben (46.42%), among others. A positive correlation was found between the number of pesticides in blood and genotoxic variables. On the other hand, mothers of children with genitourinary anomalies were the ones with the highest concentrations of ATZ and OP.

Discussion and conclusion

These results showed a deep background in the health reality of Santa Fe, which could greatly impact the health of future adults, who have been born preterm. On the other hand, the mixture of pesticides detected confirms the environmental living conditions of women and the transplacental exposure to these compounds in each pregnancy. The potential effects on long-term descendent health are unknown and unpredictable.

引言 先天性畸形(CA)的流行病学调查是一项挑战,因为相关的风险因素,尤其是环境因素具有多重性。监测不同人群的基因毒性效应是人类生物监测的有用工具,对于估计接触复杂混合化学物质的风险具有重要的生物学意义。 本研究旨在确定患有和未患有 CA 的新生儿母亲体内是否存在环境异种生物,并评估其基因毒性效应,以及这些生物标志物与 CA 之间可能存在的关联/相关性。 材料和方法 对阿根廷圣菲的 290 名产后妇女进行了一项描述性病例和对照横断面研究。 结果 观察到两组妇女在居住地和妇科变量方面存在显著差异。检测到了有机氯(OC)、有机磷(OP)和拟除虫菊酯(PYR)农药的代谢物。最常检测到的化合物是阿特拉津(ATZ)(57.14%)、多菌灵(CBZ)(46.42%)和甲基对硫磷(46.42%)等。血液中农药的数量与基因毒性变量之间呈正相关。另一方面,泌尿生殖系统异常儿童的母亲体内 ATZ 和 OP 的浓度最高。 讨论与结论 这些结果表明,圣达菲的健康现实有着深厚的背景,这可能会对早产儿未来成人的健康产生极大的影响。另一方面,检测到的杀虫剂混合物证实了妇女的生活环境条件以及每次怀孕时胎盘暴露于这些化合物的情况。对后代长期健康的潜在影响是未知的,也是不可预测的。
{"title":"Prenatal exposure to pesticide mixture in Argentina: A pilot study in puerperal women from Santa Fe province","authors":"Carlina Leila Colussi,&nbsp;Guillaume Martinez,&nbsp;Jean-Philippe Bellenger,&nbsp;Gisela Laura Poletta,&nbsp;María Fernanda Simoniello","doi":"10.1002/bdr2.2307","DOIUrl":"https://doi.org/10.1002/bdr2.2307","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The epidemiological investigation of congenital anomalies (CA) represents a challenge due to the multiplicity of associated risk factors, notably environmental ones. The monitoring of genotoxic effects in different populations is a useful tool in human biomonitoring and has great biological importance in estimating the exposure risks to complex mixtures of chemical substances.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>This study aimed to determine the presence of environmental xenobiotics and evaluate their genotoxic effect, in mothers of newborns with and without CA, and the possible association/correlation between those biomarkers and CA.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and methods</h3>\u0000 \u0000 <p>A descriptive case and control cross-sectional study was developed on 290 postpartum women from Santa Fe, Argentina.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Significant differences were observed between both groups, for places of residence and gynecological variables. Metabolites of organochlorine (OC), organophosphate (OP), and pyrethroid (PYR) pesticides were detected. The most frequently detected compounds were atrazine (ATZ) (57.14%), carbendazim (CBZ) (46.42%), and methylparaben (46.42%), among others. A positive correlation was found between the number of pesticides in blood and genotoxic variables. On the other hand, mothers of children with genitourinary anomalies were the ones with the highest concentrations of ATZ and OP.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and conclusion</h3>\u0000 \u0000 <p>These results showed a deep background in the health reality of Santa Fe, which could greatly impact the health of future adults, who have been born preterm. On the other hand, the mixture of pesticides detected confirms the environmental living conditions of women and the transplacental exposure to these compounds in each pregnancy. The potential effects on long-term descendent health are unknown and unpredictable.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139695342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Investigation of a transient increase in omphalocele prevalence in a birth cohort of TRICARE beneficiaries 调查 TRICARE 受益人出生队列中脐带绕颈症发病率的短暂上升
IF 2.1 4区 医学 Q4 DEVELOPMENTAL BIOLOGY Pub Date : 2024-01-31 DOI: 10.1002/bdr2.2305
Jackielyn Lanning, Sandra Michelle Magallon, Anna T. Bukowinski, Gia R. Gumbs, Ava Marie S. Conlin, Clinton Hall

Background

The Department of Defense Birth and Infant Health Research (BIHR) program leverages medical encounter data to conduct birth defect surveillance among infants born to military families. Omphalocele is a major abdominal wall defect with an annual prevalence of ~2 per 10,000 births in BIHR data, but an unexpected increase was observed during 2017–2019, reaching 6.4 per 10,000 births in 2018. To investigate this transient increase in prevalence, this study aimed to validate the omphalocele case algorithm among infants born 2016–2021.

Methods

Omphalocele cases were identified by ICD-10 code Q79.2 (exomphalos) on one inpatient or two outpatient infant encounter records and validated using parental and infant electronic health records. Characteristics of true and false positive cases were assessed using bivariate analyses and compared over time.

Results

Of 638,905 live births from 2016 to 2021, 230 met the ICD-10 case definition for omphalocele; 138 (60.0%) cases were eligible for validation, of which 68 (49.3%) were true positives. The geometric mean time from birth to first ICD-10 omphalocele diagnosis was 1.1 (standard error [SE] 0.1) days for true positives and 11.9 (SE 3.1) days for false positives. Among the 70 false positives, 36 (51.4%) were cases of confirmed umbilical hernia; rates of umbilical hernia and delayed omphalocele diagnoses (>30 days after birth) were elevated among false positives during 2017–2019.

Conclusions

Higher misuse of ICD-10 code Q79.2 during 2017–2019 likely influenced the associated increase in omphalocele prevalence. Timing of diagnosis should be considered for omphalocele case definitions using medical encounter data.

背景 美国国防部出生和婴儿健康研究(BIHR)计划利用医疗会诊数据对军人家庭出生的婴儿进行出生缺陷监测。脐膨出是一种主要的腹壁缺陷,在 BIHR 数据中的年患病率约为每万名新生儿中 2 例,但在 2017-2019 年期间出现了意外增长,2018 年达到每万名新生儿中 6.4 例。为了调查这种患病率的短暂增长,本研究旨在验证 2016-2021 年出生婴儿中的脐膨出病例算法。 方法 根据一名住院患者或两名门诊患者的婴儿就诊记录中的 ICD-10 代码 Q79.2(颅外畸形)确定脐膨出病例,并使用父母和婴儿的电子健康记录进行验证。使用双变量分析评估了真阳性病例和假阳性病例的特征,并对不同时期的特征进行了比较。 结果 在2016年至2021年的638905例活产中,有230例符合ICD-10对卵脐病例的定义;138例(60.0%)符合验证条件,其中68例(49.3%)为真阳性。真阳性病例从出生到首次确诊 ICD-10 脑积水的几何平均时间为 1.1 天(标准误差 [SE] 0.1),假阳性病例为 11.9 天(标准误差 3.1)。在 70 例假阳性病例中,36 例(51.4%)为确诊脐疝;2017-2019 年期间,假阳性病例中脐疝和延迟脐疝诊断(>出生后 30 天)的比率升高。 结论 2017-2019年期间ICD-10代码Q79.2的误用率较高,可能影响了相关的脐疝患病率的增加。在使用医疗会诊数据进行脐膨出病例定义时应考虑诊断时机。
{"title":"Investigation of a transient increase in omphalocele prevalence in a birth cohort of TRICARE beneficiaries","authors":"Jackielyn Lanning,&nbsp;Sandra Michelle Magallon,&nbsp;Anna T. Bukowinski,&nbsp;Gia R. Gumbs,&nbsp;Ava Marie S. Conlin,&nbsp;Clinton Hall","doi":"10.1002/bdr2.2305","DOIUrl":"https://doi.org/10.1002/bdr2.2305","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The Department of Defense Birth and Infant Health Research (BIHR) program leverages medical encounter data to conduct birth defect surveillance among infants born to military families. Omphalocele is a major abdominal wall defect with an annual prevalence of ~2 per 10,000 births in BIHR data, but an unexpected increase was observed during 2017–2019, reaching 6.4 per 10,000 births in 2018. To investigate this transient increase in prevalence, this study aimed to validate the omphalocele case algorithm among infants born 2016–2021.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Omphalocele cases were identified by ICD-10 code Q79.2 (exomphalos) on one inpatient or two outpatient infant encounter records and validated using parental and infant electronic health records. Characteristics of true and false positive cases were assessed using bivariate analyses and compared over time.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 638,905 live births from 2016 to 2021, 230 met the ICD-10 case definition for omphalocele; 138 (60.0%) cases were eligible for validation, of which 68 (49.3%) were true positives. The geometric mean time from birth to first ICD-10 omphalocele diagnosis was 1.1 (standard error [<i>SE</i>] 0.1) days for true positives and 11.9 (<i>SE</i> 3.1) days for false positives. Among the 70 false positives, 36 (51.4%) were cases of confirmed umbilical hernia; rates of umbilical hernia and delayed omphalocele diagnoses (&gt;30 days after birth) were elevated among false positives during 2017–2019.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Higher misuse of ICD-10 code Q79.2 during 2017–2019 likely influenced the associated increase in omphalocele prevalence. Timing of diagnosis should be considered for omphalocele case definitions using medical encounter data.</p>\u0000 </section>\u0000 </div>","PeriodicalId":9121,"journal":{"name":"Birth Defects Research","volume":"116 2","pages":""},"PeriodicalIF":2.1,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139676818","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Birth Defects Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1